Procurement Summary
Country : USA
Summary : Development of Rapid Donor Screening (Rds) Technology
Deadline : 29 May 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 101114220
Document Ref. No. : HT9425-24-R-0005
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Government intends to develop Rapid Donor Screening (RDS) technology that is U.S. Food and Drug Administration (FDA) cleared with a donor screening indication. The Department of Defense (DoD) is seeking multiplexed assays for HIV-1 and -2, Hepatitis B and C, blood type and Rh factor, that use a whole blood sample and provides results in 20 minutes or less. The RDS shall ultimately support screening blood from the donors in conflict zones. The DoD requires technology that is rugged, lightweight, compact, and that operates with no requirement for connectivity to a cloud domain. Please review the Request for Prototype Proposal (RPP) and attachments for further details.
Active Contract Opportunity Notice ID HT9425-24-R-0005 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA) Office ARMY MED RES ACQ ACTIVITY
General Information
Contract Opportunity Type: Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: May 10, 2024 03:16 pm EDT
Original Published Date: Apr 22, 2024 04:07 pm EDT
Updated Date Offers Due: May 29, 2024 04:00 pm EDT
Original Date Offers Due: May 22, 2024 04:00 pm EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Jun 13, 2024
Original Inactive Date: Jun 06, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN43 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; ExPERIMENTAL DEVELOPMENT
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance: Frederick, MD USA
Documents
Tender Notice
RPP-for-HT9425-24-R-0005-0001-RDS-10-May-2024.docx
Attachment-A--Statement-of-Objectives-SOO-10-May-2024.docx
Attachment-B--Objectives-to-Performance-Attributes-Crosswalk-10-May-2024.xlsx
Attachment-C--Warranties-and-Representatives.docx
Attachment-D--Statement-Of-Work-SOW-Template-22-Apr-2024.docx
Attachment-E--Draft-Agreement-Terms-and-Conditions-10-May-2024.docx
Attachment-F--Cost-Sheet-Template-22-Apr-2024.xlsx
Attachment-G--Contract-Data-Requirements-List-CDRL-03-Apr-24.pdf
Attachment-H--Data-Item-Description-DID-No.-DI-TCSP-8204.pdf
RPP-HT9425-24-R-0005-0001--Vendor-Questions-and-Government-Responses-10-May-2024.xlsx